Vimarsana
Biggest News Aggregation in the World

Page 4 - Sequenom Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sequenom Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sequenom Inc Today - Breaking & Trending Today

The Worldwide Prenatal and New-born Genetic Testing Industry is Expected to Reach $14.3 Billion by 2027: Rising Application of Genetic Testing in Oncology and Genetic Diseases Drives Growth - Vimarsana News

The Worldwide Prenatal and New-born Genetic Testing Industry is Expected to Reach $14.3 Billion by 2027: Rising Application of Genetic Testing in Oncology and Genetic Diseases Drives Growth

/PRNewswire/ -- The "Global Prenatal and New-born Genetic Testing Market (2022-2027) by Type, Technology, Application, and Geography, Competitive Analysis and...

Non-Invasive Prenatal Testing Market Is Expected To Reach Worth USD 1,939.9 Mn by 2022 - Vimarsana News

Non-Invasive Prenatal Testing Market Is Expected To Reach Worth USD 1,939.9 Mn by 2022

According to the latest report published by Credence Research, Inc. “Non-Invasive Prenatal Testing Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the non-invasive prenatal testing market was valued at USD 613.0 Mn in 2015, and is expected to reach USD 1,939.9 Mn by 2022, expanding at a CAGR of 17.9% from 2016 to 2022. Browse the full report Non-Invasive Prenatal Testing Market Growth, Future Prospects and Competitive Analysis, 2016-2022 at https://www.credenceresearch.com/report/non-invasive-prenatal-testing-market Market Insights The global non-invasive prenat...

Tips for Filing Regenerative Medicine Patents - Vimarsana News

Tips for Filing Regenerative Medicine Patents

The patent eligibility requirement of U.S. patent law creates obstacles for the regenerative medicine sector. This article examines common...

Senator Tillis' Patent Eligibility Reform Proposal: A Biopharma Perspective | McDonnell Boehnen Hulbert & Berghoff LLP - Vimarsana News

Senator Tillis' Patent Eligibility Reform Proposal: A Biopharma Perspective | McDonnell Boehnen Hulbert & Berghoff LLP

Senator Thom Tillis (R-NC) introduced S. 4734, entitled "A Bill to amend Title 35, U.S. Code, to address matters relating to patent subject matter eligibility, and for other purposes"...

CareDx, Inc. v. Natera, Inc. (Fed. Cir. 2022) | McDonnell Boehnen Hulbert & Berghoff LLP - Vimarsana News

CareDx, Inc. v. Natera, Inc. (Fed. Cir. 2022) | McDonnell Boehnen Hulbert & Berghoff LLP

Plus ça change, plus c'est la même chose - Judge Moore, in Athena Diagnostics, Inc. v. Mayo Collaborative Services, LLC stated the obvious when she said in her dissent: M...